Trial intelligence / Profile preview

Testosterone and Vitamin D in Pre-frail Hypogonadal Seniors

NCT02419105Phase 3Terminated

Sponsor
University of Zurich
Start
Sep 2015
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Testosterone TEPI patch, cholecalciferol in Hypogonadism, falls, sponsored by University of Zurich. Started Sep 2015; status: terminated.

02

Drugs

Testosterone TEPI patchcholecalciferol
03

Conditions

Hypogonadismfalls

Beyond the preview

Go deeper on NCT02419105.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02419105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call